{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Schizophrenia&page=2", "query": { "condition": "Acute Schizophrenia", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Acute+Schizophrenia&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T04:21:07.083Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01104766", "title": "Safety and Efficacy of Cariprazine in Patients With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Cariprazine", "type": "DRUG" }, { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 617, "start_date": "2010-04-23", "completion_date": "2011-12-20", "has_results": true, "last_update_posted_date": "2018-10-29", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 20, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Escondido, California + 17 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01104766" }, { "nct_id": "NCT00412620", "title": "An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "ABT-925", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Abbott", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 156, "start_date": "2006-12", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2011-04-27", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 11, "location_summary": "Anaheim, California • Cerritos, California • Garden Grove, California + 7 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Pico Rivera", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00412620" }, { "nct_id": "NCT01469039", "title": "A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "ALKS 9072", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alkermes, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 623, "start_date": "2011-12", "completion_date": "2014-03", "has_results": true, "last_update_posted_date": "2019-01-30", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 26, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Cerritos, California + 20 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01469039" }, { "nct_id": "NCT01400113", "title": "Treating Acutely Agitated Patients With Asenapine Sublingual Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Agitation" ], "interventions": [ { "name": "Asenapine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Unity Health Toronto", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 120, "start_date": "2012-04", "completion_date": "2012-12", "has_results": true, "last_update_posted_date": "2016-05-16", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 1, "location_summary": "Syracuse, New York", "locations": [ { "city": "Syracuse", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01400113" }, { "nct_id": "NCT01393613", "title": "Efficacy Study of OPC-34712 in Adults With Acute Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Acute Schizophrenia" ], "interventions": [ { "name": "OPC-34712", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 674, "start_date": "2011-07", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2015-11-26", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Escondido, California + 15 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Escondido", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01393613" }, { "nct_id": "NCT07038876", "title": "A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "ML-007C-MA BID", "type": "DRUG" }, { "name": "ML-007C-MA QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MapLight Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 307, "start_date": "2025-06-27", "completion_date": "2026-06-11", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 24, "location_summary": "Little Rock, Arkansas • Bellflower, California • Culver City, California + 21 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Culver City", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Lemon Grove", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07038876" }, { "nct_id": "NCT05227703", "title": "A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "Emraclidine 15 mg", "type": "DRUG" }, { "name": "Emraclidine 30 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 391, "start_date": "2022-07-05", "completion_date": "2024-09-11", "has_results": true, "last_update_posted_date": "2025-10-28", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 19, "location_summary": "Bentonville, Arkansas • Bellflower, California • La Habra, California + 15 more", "locations": [ { "city": "Bentonville", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "La Habra", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Sherman Oaks", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05227703" }, { "nct_id": "NCT00309699", "title": "A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bipolar Disorder", "Mood Disorders" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Quetiapine", "type": "DRUG" }, { "name": "Paliperidone ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 493, "start_date": "2006-04", "completion_date": "2007-11", "has_results": false, "last_update_posted_date": "2014-06-20", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 22, "location_summary": "Cerritos, California • Garden Grove, California • Oceanside, California + 19 more", "locations": [ { "city": "Cerritos", "state": "California" }, { "city": "Garden Grove", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Bradenton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00309699" }, { "nct_id": "NCT01234779", "title": "A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "bitopertin [RO4917838]", "type": "DRUG" }, { "name": "olanzapine", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 301, "start_date": "2011-02", "completion_date": "2012-09", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 19, "location_summary": "Little Rock, Arkansas • Cerritos, California • Oceanside, California + 16 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Pico Rivera", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01234779" }, { "nct_id": "NCT02109562", "title": "Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Schizophrenia" ], "interventions": [ { "name": "RBP-7000", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Risperidone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 354, "start_date": "2014-04", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2018-10-26", "last_synced_at": "2026-07-24T04:21:07.083Z", "location_count": 32, "location_summary": "Little Rock, Arkansas • Springdale, Arkansas • Cerritos, California + 25 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Cerritos", "state": "California" }, { "city": "Escondido", "state": "California" }, { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02109562" } ] }